ALK-B:CPH
ALK-Abello A/S
DKK 243,00
arrow_downward
-1,22%(-3,00) 1D
18 Nov., 17:00:00 GMT+1 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALK-B...
Open
DKK 246,60
High
DKK 248,00
Low
DKK 239,40
Mkt. cap
49,83 mjd
Avg. vol.
217,30 k
Volume
348,47 k
52-wk high
DKK 271,40
52-wk low
DKK 191,80
Shares outstanding
202,57 m
No. of employees
3 k
Open
DKK 246,60
High
DKK 248,00
Low
DKK 239,40
Mkt. cap
49,83 mjd
Avg. vol.
217,30 k
Volume
348,47 k
52-wk high
DKK 271,40
52-wk low
DKK 191,80
Shares outstanding
202,57 m
No. of employees
3 k
News stories
From web sources and news partners
MedWatch
·
9 uur gelede
ALK scales back German investment to offset new drug rebate
Investing.com
·
13 uur gelede
ALK at Jefferies Global Healthcare Conference: growth broadens
GuruFocus
·
19 uur gelede
ALK-Abelló A/S Reports Strong Q3 Results, Shares Trade Modestly Above GF Value™ (AKBLF)
www.tokenpost.com
·
20 uur gelede
ALK-Abelló A/S Q3 Revenue Rises 15% to DKK 1.76 Billion
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter J. Halling
Employees2,77 k
Founded1923
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealk.net